{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Indiana",
      "state": "PA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "90127",
      "recalling_firm": "RemedyRepack Inc.",
      "address_1": "625 Kolter Dr Ste 4",
      "address_2": "",
      "postal_code": "15701-3571",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Product was distributed to FL, SC and VA",
      "recall_number": "D-0887-2022",
      "product_description": "Losartan HCTZ 100/12.5 mg, 90 count bottles  NDC# 70518-2564-00 Repackaged NDC  Original NDC # 68180-0216-09",
      "product_quantity": "30 bottles/90 count = 2,700 tablets",
      "reason_for_recall": "CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.",
      "recall_initiation_date": "20220502",
      "center_classification_date": "20220520",
      "termination_date": "20220902",
      "report_date": "20220601",
      "code_info": "Lot #   B1364261-092721, exp. date 09/30/2022  B1377667-100521, exp. date 10/31/2022  B1412576-102621, exp. date 10/31/2022  B1436925-111321, exp. date 11/30/2022",
      "more_code_info": ""
    }
  ]
}